Publications by authors named "C X Raventos"
Article Synopsis
- The study aimed to compare the biomechanical properties of two types of balloon-expandable covered stents, VBX and iCover, focusing on their use as bridging stents in fenestrated aortic endoprostheses.
- Three biomechanical tests were conducted on 12 stents to assess their bending strength, pullout force, and shear-stress force by using a dynamometer and analyzing the data microscopically.
- Results showed that while VBX required more force to bend when crimped, it needed less force when expanded compared to iCover, with both types showing similar pullout force results but different shear-stress forces at various deformations.
XBM was prospectively assessed in spontaneous urine collected just before flexible cystoscopy and washing cytology carried out within the first 2 years follow-up of 337 patients with NMIBC. Recurrences were pathologically confirmed in 49 patients (14.5%), 22 of them being high-risk (6.
View Article and Find Full Text PDFIntroduction: Bladder cancer is thefifth most common tumor in the world. Moreover, it isone of the most expensive due to its high recurrencerate. Urinary biomarkers for surveillance of non muscleinvasive bladder cancer is a promising and growingfield due to the invasiveness of the actual methods, basedon cystoscopy and cytology.
View Article and Find Full Text PDFBackground: Open revision of ureteroenteric strictures (UESs) is associated with considerable morbidity. There is a lack of data evaluating the feasibility of robotic revisions.
Objective: To analyze the perioperative and functional outcomes of robot-assisted ureteroenteric reimplantation (RUER) for the management of UESs after radical cystectomy (RC).
Introduction: Robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) is a technically difficult procedure. Our aim was to evaluate the potential impact of the learning curve (LC) on perioperative and pathological outcomes of RARC with ICUD.
Material And Methods: Retrospective study of 62 consecutive patients who underwent RARC with ICUD for bladder cancer between 2015-2020.